Your account is not claimed yet. You can sign up with ORCID to claim your account.

Matthias Dobbelstein

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Venues

The EMBO journal

Proceedings of the National Academy of Sciences of the United States of America

Cancers

EMBO reports

Georg-August-Universität Göttingen Universitätsmedizin

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Georg-August-Universität Göttingen Universitätsmedizin

Germany

Director, Professor :: Institute of Molecular Oncology

Publications

Joshua Blume, Luisa Klemke, Tamara Isermann, Antje Dickmanns, Lena-Christin Conradi, Ramona Schultz-Heddergott, Matthias Dobbelstein
CDK4/6 inhibition confers protection of normal gut epithelia against gemcitabine and the active metabolite of irinotecan. Cell cycle (Georgetown, Tex.) (2023)
Oguz Bolgi, Maria Silva-Garcia, Breyan Ross, Esther Pilla, Vijayalakshmi Kari, Markus Killisch, Melanie Spitzner, Nadine Stark, Christof Lenz, Konstantin Weiss, Laura Donzelli, Mark D Gorrell, Marian Grade, Jan Riemer, Henning Urlaub, Matthias Dobbelstein, Robert Huber, Ruth Geiss-Friedlander
Dipeptidyl peptidase 9 triggers BRCA2 degradation and promotes DNA damage repair. EMBO reports 23 (10) (2022)
Katharina M Ewers, Shilpa Patil, Waltraut Kopp, Juergen Thomale, Tabea Quilitz, Anna Magerhans, Xin Wang, Elisabeth Hessmann, Matthias Dobbelstein
HSP90 Inhibition Synergizes with Cisplatin to Eliminate Basal-like Pancreatic Ductal Adenocarcinoma Cells. Cancers 13 (24) (2021)
Kester Mo Henningsen, Valentina Manzini, Anna Magerhans, Sabrina Gerber, Matthias Dobbelstein
MDM2-Driven Ubiquitination Rapidly Removes p53 from Its Cognate Promoters. Biomolecules 12 (1) (2021)
Thomas Güttler, Metin Aksu, Antje Dickmanns, Kim M Stegmann, Kathrin Gregor, Renate Rees, Waltraud Taxer, Oleh Rymarenko, Jürgen Schünemann, Christian Dienemann, Philip Gunkel, Bianka Mussil, Jens Krull, Ulrike Teichmann, Uwe Groß, Volker C Cordes, Matthias Dobbelstein, Dirk Görlich
Neutralization of SARS-CoV-2 by highly potent, hyperthermostable, and mutation-tolerant nanobodies. The EMBO journal 40 (19) (2021)
Matthias Dobbelstein, Arnold J Levine
Mdm2: Open questions. Cancer science 111 (7) (2020)
Ina Klusmann, Kai Wohlberedt, Anna Magerhans, Federico Teloni, Jan O Korbel, Matthias Altmeyer, Matthias Dobbelstein
Chromatin modifiers Mdm2 and RNF2 prevent RNA:DNA hybrids that impair DNA replication. Proceedings of the National Academy of Sciences of the United States of America 115 (48) (2018)

Matthias Dobbelstein.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Matthias Dobbelstein